Cabaletta Bio, Inc

(NASDAQ:CABA)

Latest On Cabaletta Bio, Inc (CABA):

Date/Time Type Description Signal Details
2023-05-18 16:00 ESTNewsCabaletta Bio up 1%, prices $87M offeringN/A
2023-05-18 02:29 ESTNewsCabaletta Bio commences underwritten public offering of sharesN/A
2023-05-16 23:33 ESTNewsCabaletta Bio jumps 16% as FDA clears trial for myositis candidateN/A
2023-05-11 15:27 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.02N/A
2023-05-01 18:20 ESTNewsCabaletta's potential lupus drug CABA-201 gets FDA fast track tagN/A
2023-04-28 03:16 ESTNewsCabaletta Bio: Speculative Biotech With OpportunityN/A
2023-03-31 16:02 ESTNewsCabaletta CAR T cell therapy for lupus gets FDA nod to enter trialN/A
2023-03-31 16:02 ESTNews4 stocks to watch on Friday: Amazon, Kraft Heinz, and moreN/A
2023-03-16 13:19 ESTNewsCabaletta Bio GAAP EPS of -$0.52 misses by $0.08N/A
2023-01-27 17:59 ESTNewsCabaletta rises as Morgan Stanley upgrades citing new CAR-T assetN/A
2023-01-25 12:46 ESTNewsCabaletta: Adding To Position For 36% Return Potential After CABA-201 Rally (Technical Analysis)N/A
2022-12-08 20:30 ESTNewsCabaletta Bio dips on announcing $35M offeringN/A
2022-11-10 11:40 ESTNewsCabaletta Bio GAAP EPS of -$0.39 beats by $0.09N/A
2022-08-30 16:03 ESTNewsCabaletta downgraded at Morgan Stanley on upcoming data for lead assetN/A
2022-08-11 21:46 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.05N/A
2022-05-18 20:14 ESTNewsCabaletta Bio updates Phase 1 interim data for lead assetN/A
2022-05-12 11:04 ESTNewsCabaletta Bio GAAP EPS of -$0.45N/A
2022-03-18 09:46 ESTNewsCabaletta Bio GAAP EPS of -$0.49 beats by $0.11N/A
2021-12-14 08:41 ESTNewsCabaletta Bio tanks 34% on cell therapy data in early-stage study for pemphigus vulgarisN/A
2021-11-01 14:01 ESTNewsCabaletta Bio EPS beats by $0.05N/A
2021-11-01 14:01 ESTNewsCabaletta rises as skin diseases drug shown to be safe in early data of phase 1 trialN/A
2021-08-19 00:00 ESTNewsCabaletta Bio reports results from DesCAARTes trial in patients with pemphigus vulgarisN/A
2021-08-05 20:25 ESTNewsCabaletta Bio EPS beats by $0.03N/A
2021-03-18 15:25 ESTAnalyst RatingThe Analyst Target Price has increased from $20.33 to $22.25.Buy
2021-03-18 07:46 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 17:01 ESTNewsCabaletta Bio EPS misses by $0.04N/A
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$2.18 is estimated for the 2022 year.Sell
2021-01-20 12:58 ESTNewsCabaletta: DSG3-CAART's 1H 2021 Data Release Can Substantiate This Young BiotechN/A
2021-01-11 10:22 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $20.33.Buy
2021-01-09 03:37 ESTNewsChardan Capital initiates Cabaletta Bio with Buy ratingN/A
2020-12-10 06:47 ESTNewsDosing underway in Cabaletta Bio's DSG3-CAART study in a rare skin blistering disorderN/A
2020-12-04 06:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.67 to $20.Neutral
2020-11-17 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 23:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 07:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 09:52 ESTNewsCabaletta Bio EPS beats by $0.08N/A
2020-11-11 09:52 ESTNewsCabaletta Bio +5% on Q3 results, pipeline updateN/A
2020-11-11 06:54 ESTEarnings EstimateAn EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021.Sell
2020-10-15 08:02 ESTNewsCabaletta Bio (CABA) Investor Presentation - SlideshowN/A
2020-10-14 11:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $22.5 to $21.67.Neutral
2020-10-08 21:07 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:25 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 03:29 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 23:40 ESTFinancialsCompany financials have been released.Neutral

About Cabaletta Bio, Inc (CABA):

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also include MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was founded in 2017 and is headquartered in Philadelphia, Pennsylvania.

CABA Quotes by TradingView

See Advanced Chart

General

  • Name Cabaletta Bio, Inc
  • Symbol CABA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 31
  • Fiscal Year EndDecember
  • IPO Date2019-10-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.cabalettabio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.13
  • Next Year EPS Estimate -$2.45
  • Next Quarter EPS Estimate -$0.42
  • Return on Assets -17%
  • Return on Equity -27%
  • Earnings Per Share -$0.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 276.24 million
  • Analyst Target Price $22.25
View More

Share Statistics

  • Shares Outstanding 24.06 million
  • Shares Float 7.91 million
  • % Held by Insiders 523%
  • % Held by Institutions 67.4%
  • Shares Short 1.63 million
  • Shares Short Prior Month 1.61 million
  • Short Ratio 15.52
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • 52 Week High $16.38
  • 52 Week Low $6.07
  • 50 Day Moving Average 11.96
  • 200 Day Moving Average 12.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cabaletta Bio, Inc (CABA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cabaletta Bio, Inc (CABA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.40-$0.36-11.11%
2020-09-302020-11-10$N/A-$0.36-$0.4418.18%
2020-06-302020-08-06$N/A-$0.35-$0.3910.26%
2020-03-312020-05-12$N/A-$0.33-$0.23-43.48%
2019-12-312020-03-30$N/A-$0.33-$0.4729.79%
2019-09-302019-12-05$N/A-$1.21-$2.2646.46%

Cabaletta Bio, Inc (CABA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cabaletta Bio, Inc (CABA) Chart:

Cabaletta Bio, Inc (CABA) News:

Below you will find a list of latest news for Cabaletta Bio, Inc (CABA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cabaletta Bio, Inc (CABA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-200.50CALL0 0606.93TRUE00
2026-03-2010CALL0 00TRUE00
2026-03-201.51CALL0 10TRUE00
2026-03-2021.35CALL5 60221.95TRUE00
2026-03-202.50.75CALL9 357281.87TRUE0.750
2026-03-2030.58CALL103 1166164.92TRUE0.080.16
2026-03-203.50.16CALL3 85991.23FALSE-0.04-0.2
2026-03-2040.06CALL2 37794.56FALSE-0.04-0.4
2026-03-204.50.23CALL0 301452.07FALSE00
2026-03-2050.1CALL0 40712.5FALSE00
2026-03-205.50CALL0 0958.45FALSE00
2026-03-207.50CALL0 01036.3FALSE00
2026-03-200.50PUT0 0609.53FALSE00
2026-03-2010PUT0 00FALSE00
2026-03-201.50PUT0 0323.88FALSE00
2026-03-2020PUT0 0887.88FALSE00
2026-03-202.50.03PUT3 37497.56FALSE0.030
2026-03-2030.15PUT12 33796.01FALSE0.150
2026-03-203.50.39PUT0 121305.96TRUE00
2026-03-2040PUT0 0215.07TRUE00
2026-03-204.50PUT0 00TRUE00
2026-03-2050PUT0 0180.79TRUE00
2026-03-205.50PUT0 0172.97TRUE00
2026-03-207.50PUT0 0241.55TRUE00
2026-04-170.50CALL0 0370.82TRUE00
2026-04-171.50CALL0 0195.26TRUE00
2026-04-1720CALL0 0157.18TRUE00
2026-04-172.51.1CALL0 250437.48TRUE00
2026-04-1730.63CALL0 32264.19TRUE00
2026-04-173.50.4CALL40 43108.5FALSE-0.04-0.09
2026-04-1740.2CALL0 2806101.46FALSE00
2026-04-174.50.35CALL0 33554.97FALSE00
2026-04-1750.1CALL0 100163.58FALSE00
2026-04-175.50CALL0 0588.63FALSE00
2026-04-177.50CALL0 0636.52FALSE00
2026-04-170.50PUT0 00FALSE00
2026-04-171.50PUT0 0648.04FALSE00
2026-04-1720PUT0 00FALSE00
2026-04-172.50PUT0 0776.05FALSE00
2026-04-1730PUT0 0569.53FALSE00
2026-04-173.50PUT0 0396.45TRUE00
2026-04-1740PUT0 0336.65TRUE00
2026-04-174.50PUT0 0123.24TRUE00
2026-04-1750PUT0 00TRUE00
2026-04-175.50PUT0 00TRUE00
2026-04-177.50PUT0 00TRUE00
2026-05-150.50CALL0 0414.85TRUE00
2026-05-1512.2CALL0 92180.07TRUE00
2026-05-151.52.2CALL0 189121.1TRUE00
2026-05-1521.7CALL0 146361.5TRUE00
2026-05-152.50.95CALL86 1505492.92TRUE-0.07-0.07
2026-05-1530.68CALL0 632100.48TRUE00
2026-05-153.50.59CALL73 572117.46FALSE0.090.18
2026-05-1540.4CALL60 202110.49FALSE0.40
2026-05-154.50.4CALL0 31435.33FALSE00
2026-05-1550.15CALL0 3777113.23FALSE00
2026-05-155.50CALL0 0461.79FALSE00
2026-05-157.50.1CALL0 959311.51FALSE00
2026-05-150.50PUT0 0361.02FALSE00
2026-05-1510PUT0 00FALSE00
2026-05-151.50PUT0 0630.25FALSE00
2026-05-1520.5PUT0 1187.41FALSE00
2026-05-152.50.2PUT0 447189.11FALSE00
2026-05-1530.05PUT0 0448.85FALSE00
2026-05-153.50.87PUT0 100222.68TRUE00
2026-05-1540PUT0 0114.97TRUE00
2026-05-154.50PUT0 077.03TRUE00
2026-05-1551.91PUT0 20114.03TRUE00
2026-05-155.50PUT0 0116.4TRUE00
2026-05-157.54.15PUT0 330TRUE00
2026-08-210.52.6CALL0 2185.09TRUE00
2026-08-2110CALL0 0111.84TRUE00
2026-08-211.51.7CALL0 1194.92TRUE00
2026-08-2122CALL0 5944.59TRUE00
2026-08-212.51.2CALL0 11770100.67TRUE00
2026-08-2131.2CALL4 3609127.19TRUE1.20
2026-08-213.51CALL0 88126.2FALSE00
2026-08-2140.6CALL0 14272.76FALSE00
2026-08-214.50CALL0 0260.9FALSE00
2026-08-2150.7CALL4 59129.19FALSE0.70
2026-08-215.50.46CALL0 10172.43FALSE00
2026-08-217.50CALL0 0264.62FALSE00
2026-08-210.50PUT0 00FALSE00
2026-08-2110PUT0 00FALSE00
2026-08-211.50PUT0 0547.26FALSE00
2026-08-2120PUT0 00FALSE00
2026-08-212.50.5PUT0 11405.07FALSE00
2026-08-2131.05PUT0 1296.95FALSE00
2026-08-213.50PUT0 0228.8TRUE00
2026-08-2140PUT0 0111.57TRUE00
2026-08-214.50PUT0 0119.78TRUE00
2026-08-2150PUT0 0119.99TRUE00
2026-08-215.50PUT0 0129.85TRUE00
2026-08-217.50PUT0 0135.33TRUE00
2026-09-180.52.75CALL0 120TRUE00
2026-09-1812.6CALL0 7151.29TRUE00
2026-09-181.52CALL6 60128.97TRUE20
2026-09-1821.7CALL0 7560TRUE00
2026-09-182.51.44CALL2 6450122.74TRUE1.440
2026-09-1831.2CALL0 3528120.62TRUE00
2026-09-183.51.25CALL0 356133.7FALSE00
2026-09-1840.85CALL1 34112.86FALSE0.850
2026-09-184.50.95CALL0 40146.39FALSE00
2026-09-1850.62CALL0 322101.14FALSE00
2026-09-185.50CALL0 0278.75FALSE00
2026-09-187.50.42CALL0 1026105.44FALSE00
2026-09-180.50PUT0 00FALSE00
2026-09-1810PUT0 00FALSE00
2026-09-181.50PUT0 00FALSE00
2026-09-1820PUT0 00FALSE00
2026-09-182.50.77PUT0 40376.72FALSE00
2026-09-1831.25PUT0 38136.33FALSE00
2026-09-183.51.65PUT0 7109.46TRUE00
2026-09-1841.87PUT0 35114.6TRUE00
2026-09-184.52.2PUT0 1111.69TRUE00
2026-09-1852.7PUT0 8111.96TRUE00
2026-09-185.50PUT0 0121.18TRUE00
2026-09-187.50PUT0 0100.88TRUE00
2027-01-150.53.22CALL0 2195.26TRUE00
2027-01-1512.1CALL0 12146.93TRUE00
2027-01-151.52.4CALL0 1156.21TRUE00
2027-01-1522.01CALL0 21132.89TRUE00
2027-01-152.51.75CALL0 358143.27TRUE00
2027-01-1531.75CALL0 391159.74TRUE00
2027-01-153.51.45CALL0 24145.52FALSE00
2027-01-1541.2CALL0 14146.32FALSE00
2027-01-154.51.13CALL0 20136.77FALSE00
2027-01-1551.2CALL0 877108.17FALSE00
2027-01-155.51.25CALL0 16133.88FALSE00
2027-01-150.50PUT0 00FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-151.50.65PUT0 120FALSE00
2027-01-1520.76PUT0 520FALSE00
2027-01-152.50.8PUT0 25127.57FALSE00
2027-01-1530PUT0 0146.18FALSE00
2027-01-153.50PUT0 0139.65TRUE00
2027-01-1541.96PUT0 50161.24TRUE00
2027-01-154.52.7PUT0 2142.44TRUE00
2027-01-1552.6PUT0 5142.06TRUE00
2027-01-155.53PUT0 50132.34TRUE00
2028-01-210.53.1CALL0 7168.56TRUE00
2028-01-2112.5CALL0 2180.01TRUE00
2028-01-211.51.86CALL0 44134.02TRUE00
2028-01-2122.6CALL0 292237.81TRUE00
2028-01-212.52.49CALL20 235158.16TRUE2.490
2028-01-2132.8CALL5 66210.04TRUE2.80
2028-01-213.50CALL0 0174.81FALSE00
2028-01-2142.5CALL0 10169.64FALSE00
2028-01-214.51.95CALL0 10174.56FALSE00
2028-01-2152.35CALL0 102169.14FALSE00
2028-01-215.52.1CALL15 94155.75FALSE2.10
2028-01-210.50PUT0 00FALSE00
2028-01-2110PUT0 00FALSE00
2028-01-211.50PUT0 0269.19FALSE00
2028-01-2121.1PUT5 0142.4FALSE1.10
2028-01-212.51.5PUT0 40189.57FALSE00
2028-01-2130PUT0 0207.78FALSE00
2028-01-213.52.3PUT0 4176.58TRUE00
2028-01-2140PUT0 0196.03TRUE00
2028-01-214.50PUT0 0170.23TRUE00
2028-01-2153.5PUT0 45186.08TRUE00
2028-01-215.53.9PUT0 2181.54TRUE00

Latest CABA Trades:

Date Shares Price
Jun 13, 2022 7:37 PM EST1$1.08
Jun 13, 2022 7:37 PM EST6$1.08
Jun 13, 2022 7:51 PM EST7$1.06
Jun 13, 2022 7:57 PM EST7$1.06
Jun 13, 2022 7:58 PM EST7$1.055

Cabaletta Bio, Inc (CABA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025941/0000899243-19-025941-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025942/0000899243-19-025942-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025943/0000899243-19-025943-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025946/0000899243-19-025946-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025947/0000899243-19-025947-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026016/0000899243-19-026016-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026017/0000899243-19-026017-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026018/0000899243-19-026018-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026020/0000899243-19-026020-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026345/0000899243-19-026345-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026346/0000899243-19-026346-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004509/0000899243-20-004509-index.htm
2020-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004511/0000899243-20-004511-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006864/0000899243-20-006864-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006865/0000899243-20-006865-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006867/0000899243-20-006867-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320025326/0000899243-20-025326-index.htm
2020-07-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000090266420002724/0000902664-20-002724-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963819000988/0000929638-19-000988-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963820000331/0000929638-20-000331-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919056233/0001104659-19-056233-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919057348/0001104659-19-057348-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-11-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759138/000110465919061822/0001104659-19-061822-index.htm
2019-10-24S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519273939/0001193125-19-273939-index.htm
2019-10-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519274807/0001193125-19-274807-index.htm
2019-10-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519277804/0001193125-19-277804-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312519278927/0001193125-19-278927-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519287367/0001193125-19-287367-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520005110/0001193125-20-005110-index.htm
2020-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520017724/0001193125-20-017724-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520038349/0001193125-20-038349-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520042689/0001193125-20-042689-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520090013/0001193125-20-090013-index.htm
2020-03-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520091086/0001193125-20-091086-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520115863/0001193125-20-115863-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520134391/0001193125-20-134391-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520139782/0001193125-20-139782-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520153792/0001193125-20-153792-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520211336/0001193125-20-211336-index.htm
2019-10-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001374/0001193805-19-001374-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380520000185/0001193805-20-000185-index.htm
2019-12-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459019045375/0001564590-19-045375-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/0001564590-20-013929-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020024508/0001564590-20-024508-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020037278/0001564590-20-037278-index.htm
2019-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759138/999999999519002384/9999999995-19-002384-index.htm

Cabaletta Bio, Inc (CABA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cabaletta Bio, Inc (CABA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 523%
Institutional Ownership: 6740%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-295AM Ventures V, L.P.10% Share HolderBuy454,545.0011.004,999,995.00454,545.00https://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-10-29James E Flynn10% Share HolderBuy700,000.0011.007,700,000.00700,000.00https://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm